Anne E Visser

Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model

Henk-Jan Westeneng, Thomas P. A. Debray, Anne E Visser et al. · The Lancet Neurology · 2018 · 492 citations · Full text

Prognostic Assessment, Neurodegenerative Diseases, Personalised Prediction Model +12

Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study

Ammar Al‐Chalabi, Andrea Calvo, Adriano Chiò et al. · The Lancet Neurology · 2014 · 413 citations · Full text

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Neurological Disorder +14

Prior medical conditions and the risk of amyotrophic lateral sclerosis

Meinie Seelen, Perry T.C. van Doormaal, Anne E Visser et al. · Journal of Neurology · 2014 · 98 citations

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Neurological Disorder +6

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial

Vincent Meininger, Angela Genge, Leonard H van den Berg et al. · The Lancet Neurology · 2017 · 82 citations · Full text

Amyotrophic Lateral Sclerosis, Neurological Disorder, Clinical Neurology +4

Long-Term Air Pollution Exposure and Amyotrophic Lateral Sclerosis in Netherlands: A Population-based Case–control Study

Meinie Seelen, Rosario A. Toro Campos, Jan H. Veldink et al. · Environmental Health Perspectives · 2017 · 80 citations · Full text